Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Classement en actions #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Prix de l'action
$1.51
Dernière synchronisation: 2024-08-26
Capitalisation boursière
$1.12M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Agile Therapeutics, Inc. (AGRX)

Catégorie

Bénéfices pour Agile Therapeutics, Inc. (AGRX)
Bénéfices en Jun 2024 TTM : $-15.86M
Selon les derniers rapports financiers de Agile Therapeutics, Inc., les bénéfices actuels de l'entreprise sont de $-15.86M. En 2022, l'entreprise a réalisé un bénéfice de $-30.09M, une augmentation par rapport à celui de 2021 qui était de $-74.89M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Agile Therapeutics, Inc. de 2012 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-15.86M 9.62%
2023 $-14.47M -51.92%
2022 $-30.09M -59.83%
2021 $-74.89M 44.44%
2020 $-51.85M 178.69%
2019 $-18.61M -8.15%
2018 $-20.26M -28.43%
2017 $-28.30M -11.04%
2016 $-31.82M -12.37%
2015 $-36.31M 84.02%
2014 $-19.73M 37.77%
2013 $-14.32M -38.43%
2012 $-23.26M 0.00%
Bénéfices des entreprises similaires ou concurrentes